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The Drosophila insulin/IGF receptor controls growth and size by
modulating PtdInsP(3) levels
Abstract
Understanding the control of size is of fundamental biological and clinical importance. Insulin/IGF
signaling during development controls growth and size, possibly by coordinating the activities of the
Ras and PI 3-kinase signaling pathways. We show that in Drosophila mutating the consensus binding
site for the Ras pathway adaptor Drk/Grb2 in Chico/IRS does not interfere with growth whereas
mutating the binding sites of the PI 3-kinase adaptor p60 completely abrogates Chico function.
Furthermore, we present biochemical and genetic evidence that loss of the homolog of the tumor
suppressor gene, Pten, results in increased PtdInsP(3) levels and that these increased levels are sufficient
to compensate for the complete loss of the Insulin/insulin-like growth factor receptor function. This
reduction of Pten activity is also sufficient to vastly increase organism size. These results suggest that
PtdInsP(3) is a second messenger for growth and that levels of PtdInsP(3) during development regulate
organismal size.
INTRODUCTION
In Drosophila, the homologs of the mammalian insulin
receptor (IR)/insulin-like growth factor receptor (IGFR), InR,
and insulin receptor substrates (IRS1-4), Chico, control size
(via regulation of growth and proliferation), female fertility,
and lipid metabolism during development (Fernandez et al.,
1995; Chen et al., 1996; Böhni et al., 1999; Brogiolo et al.,
2001). Similar to loss of Igf1 or Irs1 function in mice,
mutations in positive components of the Drosophila insulin
pathway cause a dramatic reduction in size (Liu et al., 1993;
Araki et al., 1994; Tamemoto et al., 1994; Stocker and Hafen
2002). Conversely, overexpression of one of the seven
Drosophila insulin-like peptides (DILP2) results in flies with
increased cell, organ, and body size (Brogiolo et al., 2001).
Moreover, the increased total lipid levels and female sterility
observed in Irs2-deleted and Neuronal Insulin Receptor Knock-
Out (NIRKO) mice are also observed in chico mutant flies
(Böhni et al., 1999; Bruning et al., 2000; Burks et al., 2000).
Thus, the Drosophila InR signaling pathway, in which these
processes are combined into a single prototypical pathway
consisting of components encoded by single genes, controls
physiological processes reminiscent of both the mammalian
IR and IGFR systems, thereby demonstrating evolutionary
conservation of function (Oldham et al., 2000a; Garofalo,
2002). 
The IR and IGFR act through IRS1-IRS4 proteins, which are
multifunctional adaptors that link insulin and IGF signaling to
the Ras/MAPK and phosphoinositide 3 ¢ -kinase (PI 3-kinase)
signaling pathways (Yenush and White, 1997). The pleckstrin
homology domain (PH) and phosphotyrosine binding domain
(PTB) of the IRS proteins are believed to mediate binding to
phosphoinositol phosphates and the juxtamembrane NPXY
motif of IR/IGFR, respectively (Yenush et al., 1997). Drk is
the Drosophila homolog of Grb2, an adaptor protein containing
SH2 and SH3 domains. It has been suggested that Grb2 may,
via its binding to IRS (Olivier et al., 1993), link insulin/IGF to
the Ras/MAPK pathway and thereby control proliferation
(Simon et al., 1993; Skolnik et al., 1993; Yenush et al., 1997).
The Drosophila homolog of the SH2 domain containing
p85 PI 3-kinase adaptor subunit, p60, binds Chico/IRS and
thereby recruits the p110 catalytic subunit of PI 3-kinase
[which converts phosphoinositol(4,5)P2 (PtdIns(4,5)P2) into
phosphoinositol(3,4,5)P3 (PtdIns(3,4,5)P3)] to the plasma
membrane (Leevers et al., 1996; Yenush et al., 1997; Stambolic
et al., 1998; Maehama and Dixon, 1999; Weinkove et al.,
1999). The p110 PI 3-kinase belongs to the class I PI 3-kinases
implicated in the metabolic effects of insulin (Vanhaesebroeck
et al., 2001). The classical effectors that mediate the biological
outcomes of insulin and IGF downstream of IRS have
been divided into two functional branches: the Ras/MAPK
proliferation pathway, and the PI 3-kinase metabolic, growth
and survival pathway (Yenush et al., 1997; Vanhaesebroeck et
al., 2001).
Hyperactivation of IGF signaling pathways is associated
with a wide variety of tumors (Valentinis and Baserga, 2001).
Components in each of these pathways have been implicated
in the initiation and progression of a wide variety of human
4103Development 129, 4103-4109 (2002)
Printed in Great Britain © The Company of Biologists Limited 2002
DEV7960
Understanding the control of size is of fundamental
biological and clinical importance. Insulin/IGF signaling
during development controls growth and size, possibly by
coordinating the activities of the Ras and PI 3-kinase
signaling pathways. We show that in Drosophila mutating
the consensus binding site for the Ras pathway adaptor
Drk/Grb2 in Chico/IRS does not interfere with growth
whereas mutating the binding sites of the PI 3-kinase
adaptor p60 completely abrogates Chico function.
Furthermore, we present biochemical and genetic evidence
that loss of the homolog of the tumor suppressor gene, Pten,
results in increased PtdInsP3 levels and that these increased
levels are sufficient to compensate for the complete loss of
the Insulin/insulin-like growth factor receptor function.
This reduction of Pten activity is also sufficient to vastly
increase organism size. These results suggest that PtdInsP3
is a second messenger for growth and that levels of
PtdInsP3 during development regulate organismal size. 
Key words: Growth, PtdInsP3, Pten, Cancer, Tumor suppressor,
Insulin, PI 3 kinase
SUMMARY
The Drosophila insulin/IGF receptor controls growth and size by modulating
PtdInsP3 levels 
Sean Oldham1, Hugo Stocker1, Muriel Laffargue2, Franz Wittwer1, Matthias Wymann2 and Ernst Hafen1,*
1Universität Zürich, Zoologisches Institut, Winterthurerstrasse 190, CH – 8057, Zürich, Switzerland
2Université de Fribourg, Institute de Biochemie, Rue du Musée 5, CH – 1700, Fribourg, Switzerland
*Author for correspondence (e-mail: hafen@zool.unizh.ch)
Accepted 10 June 2002
4104
malignancies. Because both branches are strongly implicated
in contributing to tumorigenesis, it is important to determine
the relative contribution of each pathway to the processes of
growth and proliferation, and thus tumorigenesis. We used two
types of approaches to address the relative contribution of the
two major effector branches to the processes of growth,
proliferation and organismal size control during development.
In the first, we analyzed the effects of amino acid substitutions
in the different effector sites of the Chico protein. In the second
approach, we analyzed the effects of modulating the activity of
the PI 3-kinase pathway by genetically altering the levels of
PtdInsP3 within the cells. The results obtained from both
experimental strategies provide strong evidence that in
Drosophila, the PI 3-kinase branch is necessary and
sufficient to control InR-mediated growth and proliferation.
Furthermore, the results suggest a pivotal role of cellular
PtdInsP3 levels in the control of cell growth.
MATERIALS AND METHODS
Chico effector site mutations
The sites of the mutations in the chico coding region were chosen to
substitute important conserved residues that have been determined by
structural or biochemical studies carried out in mammalian IRS
proteins (Yenush et al., 1997). The mutations were introduced using
QuickChange (Stratagene) and transgenic lines were established
according to the method of Böhni et al. (Böhni et al., 1999). The
mutants were confirmed by PCR analysis and sequencing. The
experiments were carried out with two independent insertion lines for
each of the constructs tested.
Mutant analysis
Pten2L100 is a viable hypomorphic mutation located outside of the
ORF. Pten2L117 is a strong mutation (5 basepair deletion causing a
frameshift at amino acid position 165 resulting in the insertion of 35
new codons (AYKGPKRCDNPISASICSVFFQTSLFKCSIFESKP)
before the new stop codon located in the catalytic domain) and
behaves similar to a null mutation. These mutations fail to
complement other previously identified mutations of Pten and the
lethality is rescued by a Pten genomic rescue construct, which
identifies them as alleles of Pten. Pten2L100 is a weak temperature-
sensitive mutation. Heteroallelic mutants are pupal lethal, but when
shifted from 25°C to 18°C during wandering 3rd instar stage allow
for viable heteroallelic escapers. Slightly rough eyes, concave wings,
and over-enlarged legs are occasionally observed. However, no signs
of Ras pathway hyperactivation were observed, such as multiple
photoreceptors or extra wing veins. The weighing and metabolic
assays were performed according to the methods of Böhni et al.
(Böhni et al., 1999), except that Pten heteroallelic mutant flies were
raised at 18°C.
Fertility and starvation assays
All analyses were performed in a y w background. The fertility assay
was performed by mating 15 males and females of the genotype y w;
chico1/chico1; P{w+ chicoPH1.1 or chicoPTB7.2 or chicoDrk2.1 or
chicoPI3K9 or chicowt4.2 Rescue Construct}/+ and after 1 day of egg
laying, the number of pupae was determined. The starvation assay was
performed by taking 10-15 freshly eclosed females of the indicated
genotypes and placing them in a container with a water-soaked cotton
plug. The number of viable flies was determined at each time point. 
Metabolic labeling 
Briefly, 3rd instar non-wandering larvae were phosphate starved
in phosphate-free Schneider S2 medium and then labeled with 2
mCi/sample inorganic 32P (50 mCi/ml; NEN Life Science Products).
PtdInsP3 and PtdInsP2 levels were determined as described previously
(Arcaro and Wymann, 1993). 
RESULTS
To analyze the role of the different domains of Chico/IRS
under physiological conditions, a panel of effector site mutants
was created in a genomic rescue construct for chico that
disrupts the PH or the PTB domains or the putative binding
sites of Drk/Grb2 and p60 (Böhni et al., 1999) (Fig. 1A). The
constructs include the cis-regulatory sequences that permit
expression of chico in its normal spatial and temporal pattern.
The wild-type chico construct fully restores the defects of chico
homozygous null mutants (Böhni et al., 1999). In this manner,
the effector site mutants were assayed for the ability to rescue
the three different phenotypes associated with complete loss of
Chico function: body size reduction, female sterility and lipid
alterations. The Drk/Grb2 consensus binding site mutant was
able to fully rescue the reduced weight to the same extent as
the wild-type rescue construct (Fig. 1B). Therefore, the
presence of a functional Drk binding site in Chico and thus the
link to the activation of the Ras/MAPK kinase pathway is not
required for its wild-type function. In contrast, the PH and PTB
domain mutants and the double p60 PI 3-kinase binding site
mutant were unable to rescue the reduced body weight (Fig.
1B). The latter result is surprising because InR contains
additional functional PI 3-kinase binding sites in its C-terminal
S. Oldham and others
Fig. 1. Chico PH, PTB, Drk, and PI 3-kinase effector mutants.
(A) The chico genomic rescue construct and the corresponding PH,
PTB, Drk, and PI 3-kinase effector consensus site mutants. Numbers
indicate amino acid positions (not drawn to scale). (B) The PI 3-
kinase, PH and PTB consensus sites are critically required for Chico
function in body size control, while the Drk consensus site is
dispensable. The weight of male flies carrying the various transgenes
was measured as described by Böhni et al. (Böhni et al., 1999).
(C) The PTB domain is not required for Chico control of female
fertility. The number of pupae that developed from eggs laid by an
equal number of females of the indicated genotype is shown. (D) All
the Chico effectors, except Drk, function in the control of lipid
metabolism. All assays were performed three times on at least 10
flies.
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tail (Yenush et al., 1996; Böhni et al., 1999), an extension
shared only with the C. elegans InR homolog, Daf-2, and not
the mammalian IR or IGFR (Kimura et al., 1997). This
suggests that the presence of additional p60 binding sites in the
InR C-terminal tail is not sufficient in vivo to mediate wild-
type levels of growth and proliferation in the absence of the
Chico p60 PI 3-kinase binding sites and that the InR C-terminal
tail may contribute only low levels of PI 3-kinase signaling
(Fernandez et al., 1995; Chen et al., 1996; Yenush et al., 1996).
Although the PTB domain mutant failed to restore normal body
weight, it rescued the female sterility associated with the loss
of Chico function (Fig. 1C). With the exception of the full
rescue of the lipid accumulation observed in Drk/Grb2 mutant,
all the other effectors only partially restored the
change in lipid accumulation (Fig. 1D). 
The inability of the p60 binding site mutant to
rescue the size defect indicates that the Chico PI 3-
kinase docking sites are necessary for InR/Chico
(insulin/IGF) action in size control. However, the
issue of whether recruitment of PI 3-kinase to Chico
is sufficient to mediate the attainment of wild-type
body size is unresolved. It has been reported that
overexpression of PI 3-kinase and Akt in Drosophila
is sufficient for increased growth but not proliferation
(Verdu et al., 1999; Weinkove et al., 1999). Loss of
zygotic InR function results in embryonic lethality
with some small arrested larvae, but loss of zygotic
Chico function results in viable small flies (Fernandez
et al., 1995; Chen et al., 1996; Böhni et al., 1999;
Brogiolo et al., 2001). Two parsimonious hypotheses
could explain this difference. (1) InR activates not
only the PI 3-kinase pathway but also another, Chico-
independent, signal transduction pathway, or (2) InR signals
predominantly through PI 3-kinase, but loss of Chico does not
block PI 3-kinase activation completely because of direct
interaction of p60 with the InR C-terminal tail. This provides
residual PI 3-kinase activation sufficient to rescue viability, but
not wild-type size. If the latter hypothesis were true, then
increasing PtdInsP3 levels should be sufficient to rescue loss
of InR function.
To test whether increasing PtdInsP3 levels in an InR or PI
3-kinase p110 mutant background is sufficient to restore
growth, we eliminated the function of a negative regulator of
the insulin pathway. The 3 ¢ -phosphoinositol-specific lipid
phosphatase, PTEN acts as a negative regulator of the PI 3-
Fig. 2. Loss of PTEN function rescues InR null mutations.
(A) Pten2L117/Pten2L100 mutant larvae have increased
PtdInsP3 levels. Data are presented as PtdInsP3:PtdInsP2
ratios and are standardized to the wild-type y w control.
The experiment was performed twice with quantitatively
similar results. (B) The Pten2L117/Pten2L100 mutant larva
(top) is increased in size compared to the y w control.
(C) Scanning electromicrograph (SEM) of a dorsal view of
a y w control fly. Bar (above C) is 200 m m in all cases.
(D) Loss of PTEN function (Pten2L117/Pten2L117)
selectively in the head using the eyFlp system (Newsome
et al., 2000) results in the overproliferation of the head.
(E) Loss of InR function (InR327/InR327) selectively in the
head using the eyFlp system results in a pinhead.
(F) Concomitant loss of InR and PTEN function
(Pten2L117/Pten2L117; InR327/InR327) in the head is
sufficient to suppress the growth and proliferation defect
associated with InR single mutants. (G) The 2nd instar
lethality associated with the InR304/InR327 allelic
combination is rescued to the pharate adult stage in the
Pten2L117/Pten2L100; InR304/InR327 double mutant
combination (left). (Right) A y w control. (H) The
frequency of rescue to the pupal stage of InR304/InR327
(InR1) (n=15 crosses) and InR304/InR25 (InR2) (n=5
crosses) by the partial loss-of-function Pten2L117/Pten2L100
combination. ‘Expected’ denotes the expected Mendelian
frequency for complete rescue to the pupal stage for the
genotype: y w; Pten2L117/Pten2L100; InR304/InR327 from the
cross (y w; Pten2L117; InR304/Cyo^TM6B · y w; Pten2L100;
InR327/Cyo^TM6B).
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kinase pathway by converting PtdInsP3 generated by PI 3-
kinase into PtdInsP2 (Stambolic et al., 1998; Maehama et al.,
1999). We utilized a null (Pten2L117) and a hypomorphic
(Pten2L100) allele of Pten which were identified in a screen for
genes involved in growth control (Oldham et al., 2000b). As
shown by HPLC analysis of the phospholipids in extracts of
Pten mutant larvae, the loss of PTEN function results in a 2-
fold increase in PtdInsP3 levels (Fig. 2A). This is consistent
with the increase in PtdInsP3 seen in Pten-deleted murine
fibroblasts (Stambolic et al., 1998). One prominent biological
effect of these increased PtdInsP3 levels in Drosophila is a
substantial increase in size in both larvae and pupae (Fig. 2B).
To test whether loss of PTEN function, and consequently
increased PtdInsP3 levels, is sufficient to restore growth or
viability in InR null mutants, we first generated InR and Pten
double mutants by creating mosaic animals using the eyeless-
Flipase (eyFlp) tissue-specific recombination system
(Newsome et al., 2000). In such animals, the head consists of
homozygous mutant tissue, whereas the rest of the
body is heterozygous for the same mutation. While
loss of PTEN function (Pten2L117) in the head results
in a fly with a disproportionately larger head (with
more and larger cells), loss of InR function (InR327)
results in flies with smaller heads (pinhead) compared
to the wild type (Fig. 2C,D,E, Fig. 3A). Heads doubly
mutant for Pten2L117and InR327, however, are almost
the size of heads singly mutant for Pten2L117 (Fig. 2F,
Fig. 3A). Secondly, two different lethal heteroallelic
InR combinations (InR304/InR327 or InR304/InR25)
(Fernandez et al., 1995; Chen et al., 1996), which
arrest at the 2nd larval instar stage, develop to the pupal
stage (15-17% of 33% expected) and even to pharate
adults in the presence of reduced PTEN levels
(Pten2L117/Pten2L100) (Fig. 2G,H). These results
demonstrate that complete loss of PTEN function
can largely substitute for InR-mediated growth and
proliferation in the absence of InR function and that
the Ras/MAPK pathway plays little or no role in the
InR mediated control of cell growth. This notion is
further supported by the observation that complete
loss of InR function in the compound eye does not
result in a loss of photoreceptors, a hallmark of loss
of Ras pathway function (Brogiolo et al., 2001). 
As increasing PtdInsP3 levels can rescue loss of
InR function, these results suggest that the level of
PtdInsP3 may be critical in determining the amount
of growth. We explored this possibility by examining
genetic interactions between Pten and PI 3-kinase
p60 and p110. The lethality associated with the
complete loss of PI 3-kinase p110 function, cannot
be rescued by Pten2L117/Pten2L100 (data not shown).
It is possible that without any PI 3-kinase p110
function, PTEN function becomes obsolete. In order
to test this possibility, double mosaic clones were
generated with the strong loss of function Pten2L117
allele and a null mutation for PI 3-kinase p110 or its
p60 adaptor (Weinkove et al., 1999). As shown in
Fig. 3A,C,D, loss of PTEN function (Pten2L117) is
unable to rescue the pinhead phenotype caused by
loss of PI 3-kinase p110 function. Clones that are
doubly mutant for PI 3-kinase p60 and Pten2L117,
however, are of wild-type size (Fig. 3A,B,E,F). In the
absence of PI 3-kinase p60 function, PI 3-kinase
p110 might have residual activity as suggested by the
weaker phenotype of the PI 3-kinase p60 null mutant
(Weinkove et al., 1999). Indeed, flies doubly mutant
for PI 3-kinase p60 and Pten2L117/Pten2L100 flies are
viable (data not shown). These data provide strong
genetic support for the close relationship between
PTEN and PI 3-kinase and indicate that the
S. Oldham and others
Fig. 3. PtdInsP3 levels control the range of growth and size. (A) Quantification
of the eye size of the various mutants. Measurements were made from SEM
images by calculating the longest distance of a side view of the eye from dorsal
to ventral plus anterior to posterior (n=4-7). The same pattern was also seen
when head:thorax ratios were determined from a dorsal view (data not shown).
(B) Dorsal view SEM of a y w control fly. Bar above C is 200 m m in all cases.
(C) Selective loss of PI 3-kinase p110 function in the head using the eyFlp
system results in a strong pinhead phenotype. (D) Loss of PTEN function
cannot rescue complete loss of PI 3-kinase p110 function in mosaic clones. The
genotype of the fly head shown is Pten2L117/Pten2L117; PI 3-kinasenull/PI 3-
kinasenull. (E) Selectively loss of PI 3-kinase p60 function in the head using the
eyFlp system results in a strong pinhead phenotype. (F) Loss of PTEN function
rescues to wild-type size complete loss of Pi3K p60 function in mosaic clones.
The genotype of the fly head shown is Pten2L117/Pten2L117; PI3K
p60null/Pi3Kp60null.
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intracellular levels of PtdInsP3 define the amount of cellular
growth. 
Because loss of Chico function results in increased lipid
levels as well as a dramatic decrease in body size (Böhni et al.,
1999), we determined whether PTEN might also have a
function in metabolic and body size control like Chico. As seen
in Fig. 4A,B, partial loss of PTEN function results in flies
that are considerably bigger than controls. They weigh
approximately 50 percent more than their heterozygous
siblings without showing any apparent effect on cell
differentiation. The increase in size is due to an increase in both
cell size and number as determined by a morphometric analysis
of the wing and eye (data not shown). When the levels of lipids
and glycogen were measured, a decrease per mass in lipid and
glycogen was observed compared to Pten mutant flies rescued
by a genomic Pten transgene (Fig. 4C). One biological
outcome of this difference is a twofold increase in the rate of
mortality under water-only starvation conditions compared to
a 2-fold decrease in chico mutant flies (Fig. 4D). Thus lipid
and glycogen levels strongly correlate with the survival time
under starvation conditions. Since Chico and PTEN activity
regulates growth during development and the accumulation of
energy stores in the adult, the effects of InR-mediated growth
and lipid/glycogen metabolism must diverge downstream of
Pten. 
DISCUSSION
In this paper, we have used two approaches to investigate, in
Drosophila, the relative contributions of the two main effector
pathways activated in response of IR/IGF receptor stimulation,
the Ras/MAPK and the PI 3-kinase pathway. First, by mutating
the consensus binding sites for the two pathway adaptors,
Grb2/Drk and p85/p60, in Chico/IRS we showed that the
growth promoting function of Chico is dependent on the
p60/p85 binding sites but not on the Drk binding site. These
results suggest that recruiting PI 3-kinase but not Drk to Chico
is essential for cell and organismal growth. Second, we
demonstrate that the growth deficit associated with the loss of
InR function is fully compensated by loss of PTEN function.
This suggests that the levels of PtdInsP3 in the cell control the
amount of cellular growth. Finally, we show that partial loss of
PTEN function increases body size and decreases lipid and
glycogen stores in the adult suggesting that the levels of
PtdInsP3 also control metabolism in the adult. 
Viable allelic combinations of insulin receptor pathway
components result in at least three characteristic phenotypes:
small body size, female sterility and increased lipid content
(Chen et al., 1996; Böhni et al., 1999). The results from the
chico effector mutants permit the separation of the three
different Chico phenotypes.
(1) Size and fertility. Is there a causal link between the small
body size and female sterility? The PTB domain mutant
rescues the sterility, but not the size defect, thus separating the
growth and the sterility phenotypes. It remains to be resolved
whether different levels of PI 3-kinase activation are needed to
restore growth and fertility or whether control of fertility
involves at least in part the association of Chico with a different
receptor which does not require the PTB domain. For the
growth regulatory function of Chico, a functional PTB and PH
domain are essential. This indicates that in vivo, in the absence
of overexpression, these two domains serve non-redundant
functions presumably in the localization to the membrane and
binding to the insulin/IGF receptor. 
(2) Size and lipids. Does the small size cause the increased
lipid levels? Chico mutant flies lacking functional p60/PI 3-
kinase binding sites, PTB or PH domains are all small, yet the
increase in lipid levels is less pronounced than in chico null
mutant flies. Also, the Irs2-deleted mice and insulin pathway
Fig. 4. Pten regulates size, metabolism
and survival in an opposite manner to
positive components of the insulin
pathway like Chico. (A) A
Pten2L117/Pten2L100 mutant fly (right)
compared to the y w control (left).
(B) Pten2L117/Pten2L100 mutant flies
weigh more than the y w control (data
not shown) or to Pten mutants rescued
with the Pten genomic rescue construct
(n=10). (C) Pten2L117/Pten2L100 mutant
flies have decreased glycogen and lipids
compared to the y w control (data not
shown) or to Pten mutants rescued with
the Pten genomic rescue construct
(n=10). The glycogen data are
transformed by one log10 power.
(D) Pten2L117/Pten2L100 mutant flies are
hypersensitive to water-only starvation
conditions compared to a starvation
resistant chico1/chico1 mutant. All assays
were performed at least 2 times
independently.
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mutants in C. elegans are not small, yet display increased lipids
(Kimura et al., 1997; Burks et al., 2000). Therefore, there
seems to be no direct correlation between developmental
growth and energy stores in the adult.
(3) Lipids and sterility. Like chico flies, mice mutant for
IRS2 or lacking insulin receptor function in the brain (NIRKO)
display increased lipids and are female sterile. Are the
increased lipid levels a sign of metabolic dysfunction that leads
to the female sterility? The chico PI 3-kinase, PTB and PH
effector mutants have similar lipid increases, yet the PTB
mutant is fertile while the PI 3-kinase mutant is not. Therefore,
there appears to be no direct correlation between lipid
accumulation and sterility in Drosophila. 
The rescue of lethal, null InR mutant combinations to near
viability by reducing PTEN activity strengthens the argument
that a PtdInsP3-dependent signaling pathway is the primary
effector for InR-derived growth and proliferation. In support of
this observation, PI 3-kinase and Akt have been isolated
as retroviral oncogenes, suggesting that activation of PI 3-
kinase and Akt is sufficient to mediate growth, proliferation,
and oncogenesis in vertebrate systems (Bellacosa et al.,
1991; Chang et al., 1997). In Drosophila and mammals,
overexpression of PI 3-kinase causes increased growth; but this
is not sufficient for proliferation as is removal of Pten (Klippel
et al., 1998; Goberdhan et al., 1999; Huang et al., 1999;
Weinkove et al., 1999; Gao et al., 2000). From this premise, it
has been proposed that PI 3-kinase and PTEN regulate similar
yet distinct pathways (Gao et al., 2000). Alternatively, it is
possible that they do function uniquely in the same pathway
and that the difference may be due to altered location and
function because of overexpression, or to differential feedback
of PI 3-kinase versus PTEN. For example, as PI 3-kinase has
been shown to act as a serine/threonine protein kinase on IRS,
this may have a negative feedback effect on the insulin pathway
that might not be evident in Pten loss-of-function mutations
(Pirola et al., 2001). Nevertheless, PI 3-kinase is absolutely
critical in controlling size because using an allelic series of PI
3-kinase mutants in combination with the ey-Flp sytem
resulted in a range of different head sizes (data not shown).
Furthermore, expressing an activated and dominant-negative
form of PI 3-kinase in Drosophila imaginal discs or the heart
of the mouse also leads to a corresponding increase or decrease
in cell and organ size (Weinkove et al., 1999; Shioi et al.,
2000). Thus, the PI 3-kinase/PTEN cycle can be considered a
dedicated growth rheostat, and the InR pathway is an
evolutionary conserved module for regulating the range of
growth and size.
Loss of PTEN function results in a metabolically similar
phenotype to loss of murine PTP1B (Ptpn1), an IR-specific
tyrosine phosphatase, in that hyperactivation of the IR pathway
causes resistance to high-fat-diet-induced obesity because of
increased basal metabolism (Elchebly et al., 1999; Klaman et
al., 2000). These metabolic lipid effects have likely been
conserved during evolution because the increased lipid levels
in chico mutants are reminiscent of the enhanced lipid content
in Irs2 deleted and NIRKO mice (Bruning et al., 2000; Burks
et al., 2000). 
Collectively, these data firmly establish Drosophila as a
valid model organism for the study of metabolic diseases like
diabetes and obesity as well as for the study of growth
disorders like cancer. Pten mutant flies are larger in size due
to increased cell size and number, but have a corresponding
decrease in energy stores, a situation completely opposite to
mutations in positive components of the insulin signaling
pathway like InR, chico, PI 3-kinase, and dAkt. These large
viable Pten mutants show that a reduction of PTEN function
is sufficient for increased organism size. This fact suggests that
the four-fold size difference between viable InR and Pten
mutants can simply be controlled by the amount of PtdInsP3
and this phenomenon may possibly be extended to vertebrate
size regulation. Thus, in Drosophila, the InR/PI 3-kinase/
PTEN pathway combines both metabolism and growth control
into one pathway that later diverged into two separate, yet
interacting systems in mammals. 
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